Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cosmos Health (COSM) Current Deferred Revenue (2018 - 2021)

Cosmos Health's Current Deferred Revenue history spans 5 years, with the latest figure at $19378.0 for Q2 2021.

  • Quarterly results put Current Deferred Revenue at $19378.0 for Q2 2021, down 87.46% from a year ago — trailing twelve months through Jun 2021 was $19378.0 (down 87.46% YoY), and the annual figure for FY2020 was $22340.0, down 90.97%.
  • Current Deferred Revenue for Q2 2021 was $19378.0 at Cosmos Health, down from $22761.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $1.1 million in Q1 2019 to a low of $18752.0 in Q3 2020.
  • The 4-year median for Current Deferred Revenue is $154567.0 (2020), against an average of $285332.9.
  • Peak annual rise in Current Deferred Revenue hit 59.86% in 2020, while the deepest fall reached 90.97% in 2020.
  • Year by year, Current Deferred Revenue stood at $1.1 million in 2018, then crashed by 76.83% to $247318.0 in 2019, then crashed by 90.97% to $22340.0 in 2020, then dropped by 13.26% to $19378.0 in 2021.
  • According to Business Quant data, Current Deferred Revenue over the past three periods came in at $19378.0, $22761.0, and $22340.0 for Q2 2021, Q1 2021, and Q4 2020 respectively.